Natural Extracts and Bioactive Derivatives: Strategies for Biopharmaceutical Uses
A special issue of Sci (ISSN 2413-4155). This special issue belongs to the section "Biology Research and Life Sciences".
Deadline for manuscript submissions: closed (20 January 2023) | Viewed by 4516
Special Issue Editors
Interests: antimicrobial peptides; antibacterial; antibiotics; structure-activity relationships; bacteriocins; drug design; peptide engineering
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear colleagues,
For millennia, natural extracts have been known to treat human diseases and are an important source of medicines. To this day, many people around the world still use traditional drugs extracted from plants or animal secretions. Plant essences largely dominate those of animals in this area. Indeed, many drugs are derived from plants and are currently marketed. As for animal extracts, they are also gradually positioning in the pharmaceutical market. Animal venoms and their bioactive molecules are the subject of intense scientific research, and many patents in the field have been awarded. The therapeutic value of animal venoms depends on their use at appropriate doses or encapsulation/formulation in suitable vesicles in order to enable them to enter into the target cells or to minimize their cytotoxicity, if any. The potential synergistic effects of molecules derived from natural extracts have been widely demonstrated. Such synergy between compounds deserves to be examined in more depth by researchers in the coming years.
This Special Issue titled “Natural Extracts and Bioactive Derivatives: Strategies for Biopharmaceutical Uses” consists of a collection of original research and review articles concerning new advances in (i) the discovery, development and application of natural extracts in biopharmaceuticals; (ii) the potential of molecules derived from natural extracts in various fields of research; (iii) the synergy between such natural compounds for greater beneficial effects; and (iv) strategies for rectifying the activity of the biomolecules. The topics of interest for articles include the activities of crude extracts, the bio-guidance of a valued fractionation and the characterization of new value-added biomolecules. The targeted biological properties include antioxidant, antimicrobial, anticancer, and other effects.
Dr. Jean-Marc Sabatier
Prof. Ziad Fajloun
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Sci is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Bioactive molecules
- Venom derivatives
- Plant extracts
- Anticancer
- Antimicrobial
- Toxins
- Enzymes extracted
- Natural medicines
